Business Services Global On demand · 24-48h

Global GMP Laboratory Testing Service Market Strategic Research Report

Global GMP Laboratory Testing Service Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global GMP Laboratory Testing Service Market
$1.55B2025
5.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Product Validation Testing, Bioanalytical Services, Packaging & Shelf-Life Testing, Other

By Application: Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Eurofins Scientific, Almac, American Testing Lab Inc., EMSL Analytical, Inc, Intertek, North American Sciences Associates, LLC, PPD, Inc, Wuxi Apptec, Sartorius AG, Boston Analytical Services, Pace Analytical, Pearl River Labs, Marfleet Analytics, Nelson Labs, ChRi Labs, NMI Technologietransfer GmbH, BJP Laboratories Pty Ltd, Broughton Group

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 128 pages
Market size 2025
$1.55B
Billion USD
Forecast CAGR
5.8%
2025-2032
Forecast 2032
$2.3B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global GMP Laboratory Testing Service market size is predicted to grow from US$ 1,549 million in 2025 to US$ 2,283 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.

Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product.GMP testing service is a system that consists of processes, procedures and documentation that ensures manufacturing service such as pharmaceutical service that is consistently produced and controlled according to set quality standards.

The global GMP (Good Manufacturing Practice) laboratory testing service market refers to the market for outsourced testing services that adhere to the quality standards and regulations set by Good Manufacturing Practices. GMP ensures that pharmaceutical, biotechnology, medical device, and other industries maintain high-quality manufacturing processes and products.

The market for GMP laboratory testing services has been growing due to the increasing complexity of manufacturing processes, stricter regulatory requirements, and the need for specialized expertise in testing and analysis. Pharmaceutical and biotechnology companies, as well as contract manufacturing organizations (CMOs), often outsource their testing needs to specialized GMP laboratories.

Key factors driving the growth of the global GMP laboratory testing service market include:

Regulatory Compliance: Stringent regulations imposed by regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), require companies to conduct GMP-compliant testing of their products. This drives the demand for GMP laboratory testing services to ensure compliance and product safety.

Quality Control and Assurance: GMP laboratory testing services play a critical role in ensuring the quality, purity, potency, and safety of pharmaceutical products, medical devices, and biologics. These services encompass a wide range of testing, including analytical chemistry, microbiology, stability testing, method validation, and more.

Increasing Outsourcing Trend: Many pharmaceutical and biotechnology companies are outsourcing their testing requirements to external GMP laboratories to reduce costs, access specialized expertise, and improve operational efficiency. This trend further fuels the growth of the GMP laboratory testing service market.

Focus on R&D: The continuous need for research and development activities in the pharmaceutical and biotechnology sectors drives the demand for GMP laboratory testing services, as these services support product development, clinical trials, and formulation optimization.

Growing Biopharmaceutical Industry: The rapid growth of the biopharmaceutical sector, including biologics and biosimilars, necessitates specialized testing services to ensure the safety and efficacy of these complex products.

Increasing Outsourced Manufacturing: With the rise of contract manufacturing organizations (CMOs) and the outsourcing of manufacturing processes, there is a greater demand for GMP laboratory testing services to ensure the quality of the outsourced products.

Geographically, North America, Europe, and Asia Pacific are major contributors to the global GMP laboratory testing service market, driven by the presence of a robust pharmaceutical industry, stringent regulations, and increasing outsourcing trends.

In summary, the global GMP laboratory testing service market is growing due to the need for compliance with regulatory standards, quality control requirements, outsourcing trends, and the expansion of the pharmaceutical and biotechnology sectors. The market is expected to continue its growth trajectory as companies rely on specialized GMP laboratories for reliable and accurate testing services.

This report presents a comprehensive overview of the global GMP Laboratory Testing Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Product Validation Testing
  • Bioanalytical Services
  • Packaging & Shelf-Life Testing
  • Other

Segment by Application

  • Pharmaceutical and Biopharmaceutical Companies
  • Medical Device Companies

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global GMP Laboratory Testing Service market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global GMP Laboratory Testing Service Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.55B
2025
Forecast
$2.3B
2032
CAGR
5.8%
2025–2032
Regions
5
global
Key companies
Eurofins ScientificAlmacAmerican Testing Lab Inc.EMSL Analytical, IncIntertekNorth American Sciences Associates, LLCPPD, IncWuxi Apptec
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Product Validation TestingBioanalytical ServicesPackaging & Shelf-Life TestingOther
By Application
Pharmaceutical and Biopharmaceutical CompaniesMedical Device Companies

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Product Validation Testing
  • 3.1.3 Bioanalytical Services
  • 3.1.4 Packaging & Shelf-Life Testing
  • 3.1.5 Other
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceutical and Biopharmaceutical Companies
  • 4.1.3 Medical Device Companies
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Eurofins Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Almac
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 American Testing Lab Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 EMSL Analytical, Inc
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Intertek
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 North American Sciences Associates, LLC
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 PPD, Inc
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Wuxi Apptec
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Sartorius AG
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Boston Analytical Services
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Pace Analytical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Pearl River Labs
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Marfleet Analytics
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Nelson Labs
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 ChRi Labs
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 NMI Technologietransfer GmbH
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 BJP Laboratories Pty Ltd
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Broughton Group
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global GMP Laboratory Testing Service market?
The global GMP Laboratory Testing Service market is estimated at US$ 1.55 billion in 2025 (base year) and is projected to reach US$ 2.28 billion by 2032.
How fast is the GMP Laboratory Testing Service market expected to grow?
The market is expected to grow at a CAGR of 5.8% from 2026 to 2032, expanding from US$ 1.55 billion in 2025 to US$ 2.28 billion in 2032, roughly 1.5 times its base-year value.
What does the GMP Laboratory Testing Service market cover?
Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product.GMP testing service is a system that consists of processes, procedures and documentation that ensures manufacturing service such as pharmaceutical service that is consistently produced and controlled according to set quality standards.
What are the main segments of the GMP Laboratory Testing Service market by type?
By type, the market is segmented into Product Validation Testing, Bioanalytical Services, Packaging & Shelf-Life Testing and Other.
Which applications drive demand in the GMP Laboratory Testing Service market?
Key applications covered include Pharmaceutical and Biopharmaceutical Companies and Medical Device Companies.
Who are the key players in the GMP Laboratory Testing Service market?
Key players profiled include Eurofins Scientific, Almac, American Testing Lab Inc., EMSL Analytical, Intertek, North American Sciences Associates, PPD and Wuxi Apptec, among 18 companies covered in total.
Which regions and countries are covered for GMP Laboratory Testing Service?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the GMP Laboratory Testing Service market?
Key factors driving the growth of the global GMP laboratory testing service market include:
Who should buy the GMP Laboratory Testing Service market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical and Biopharmaceutical Companies and Medical Device Companies, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the GMP Laboratory Testing Service market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.